YTHDF2 and hepatocellular carcinoma: Notably, the depletion of YTHDF2, in a hypoxia-inducible factor-2α (HIF-2α)-dependent manner, has been shown to promote HCC cell growth, inflammation, metastasis, and vasculature remodeling.